In patients with genetic DCM, cardiac conduction abnormalities may suggest a specific gene defect [e.g., lamin A/C mutations (LMNA) or SCN5A mutations], while elevated serum creatine kinase or muscle weakness points to other genetic substrates (e.g., muscular dystrophy or LMNA mutation) (23). This evidence concerns the gene LMNA and muscular dystrophy.